Azaflavones Compared to Flavones As Ligands to the Benzodiazepine Binding Site of Brain GABA(A) Receptors
Overview
Affiliations
A series of azaflavone derivatives and analogues were prepared and evaluated for their affinity to the benzodiazepine binding site of the GABA(A) receptor, and compared to their flavone counterparts. Three of the compounds, the azaflavones 9 and 12 as well as the new flavone 13, were also assayed on GABA(A) receptor subtypes (alpha(1)beta(3)gamma(2s), alpha(2)beta(3)gamma(2s), alpha(4)beta(3)gamma(2s) and alpha(5)beta(3)gamma(2s)), displaying nanomolar affinities as well as selectivity for alpha1- versus alpha2- and alpha3-containing receptors by a factor of between 14 and 26.
Eymery M, Tran-Nguyen V, Boumendjel A Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832909 PMC: 8619038. DOI: 10.3390/ph14111127.
Rational approaches for the design of various GABA modulators and their clinical progression.
Bhagat K, Singh J, Pagare P, Kumar N, Sharma A, Kaur G Mol Divers. 2020; 25(1):551-601.
PMID: 32170466 PMC: 8422677. DOI: 10.1007/s11030-020-10068-4.
7-Meth-oxy-2-phenyl-quinoline-3-carbaldehyde.
Hayour H, Bouraiou A, Bouacida S, Benzerka S, Belfaitah A Acta Crystallogr Sect E Struct Rep Online. 2014; 70(Pt 2):o195-6.
PMID: 24764906 PMC: 3998345. DOI: 10.1107/S1600536814001457.
Fatokun A, Liu J, Dawson V, Dawson T Br J Pharmacol. 2013; 169(6):1263-78.
PMID: 23550801 PMC: 3831707. DOI: 10.1111/bph.12201.